Amlodipine Besylate And Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 43598-313

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Atorvastatin Calcium (NDC 43598-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Label for Amlodipine besylate and Atorvastatin calcium tablets 2.5 mg/10 mg, film-coated tablets. The label indicates a pack of 30 tablets for oral use, labeled Rx only. It includes a QR code for patient information and storage instructions. The product is manufactured by Dr. Reddy's Laboratories Inc.*

FDA Label Image

Container10 (Container10)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 10 mg/40 mg, film-coated oral tablets, in a 30-tablet package. The label includes directions to dispense with a patient information sheet and identifies Dr. Reddy's Laboratories Inc as the labeler. It also displays a barcode, QR code, and storage instructions.*

FDA Label Image

Container11 (Container11)

Packaging label for Amlodipine besylate and Atorvastatin calcium Tablets, 10 mg/80 mg strength. The label indicates 30 film-coated tablets for oral use, prescription only. It includes usage instructions, pharmacist advisory, storage conditions, manufacturer information (Dr. Reddy's Laboratories Limited, Bachupally, India), a barcode, QR code for patient information, and a National Drug Code (NDC 43598-313-30).*

FDA Label Image

Container2 (Container2)

Label for Amlodipine besylate and Atorvastatin calcium tablets, 2.5 mg/20 mg strength, in a 30-tablet package. The film-coated oral tablets are prescription-only, distributed by Dr. Reddy's Laboratories Inc. The label includes dosage details, storage instructions, a barcode, and a QR code for patient information.*

FDA Label Image

Container3 (Container3)

Amlodipine besylate and Atorvastatin calcium Tablets 2.5 mg/40 mg label for a bottle containing 30 film-coated tablets. The label includes dosage information, storage instructions, a barcode, and the labeler name, Dr. Reddy's Laboratories Limited. The label emphasizes dispensing with a patient information sheet and provides a QR code linked to the patient information sheet.*

FDA Label Image

Container4 (Container4)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 5 mg/10 mg, Rx only, containing 30 film-coated tablets. The label includes dosage information, a patient information sheet notice, the Dr. Reddy's Laboratories Inc logo, NDC 43598-322-30, and a barcode with a QR code for patient information.*

FDA Label Image

Container5 (Container5)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 5 mg/20 mg, film-coated oral tablets, containing 30 tablets, labeled for prescription use only. The label states the active ingredients and dosage strength, includes a patient information sheet reminder, and displays the Dr. Reddy's Laboratories Inc. logo and contact information.*

FDA Label Image

Container6 (Container6)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 5 mg/40 mg, film-coated tablets supplied in a package of 30 tablets. The label includes the NDC 43598-316-30, directions to dispense with a patient information sheet, storage instructions, and a barcode. The labeler is Dr. Reddy's Laboratories Limited, India.*

FDA Label Image

Container7 (Container7)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 5 mg/80 mg film-coated tablets. The label states Rx Only with a count of 30 tablets and instructs pharmacists to dispense with a patient information sheet. It is manufactured by Dr. Reddy's Laboratories Limited, with storage and dosage instructions included alongside a barcode and a QR code linking to patient information.*

FDA Label Image

Container8 (Container8)

Label for Amlodipine besylate and Atorvastatin calcium Tablets 10 mg/10 mg, film-coated tablets, 30 count. The label includes directions for the pharmacist to dispense with a patient information sheet, storage instructions, dosage information, and a barcode. It is labeled for prescription use only and manufactured by Dr. Reddy's Laboratories Limited.*

FDA Label Image

Container9 (Container9)

Amlodipine besylate and Atorvastatin calcium Tablets 10 mg/20 mg film-coated tablets carton label. The package contains 30 tablets and is labeled for prescription use only. It includes the NDC 43598-318-30 and is manufactured by Dr. Reddy's Laboratories Inc. The label has dosage and storage instructions, a QR code, and a barcode.*

FDA Label Image

Figure1 (Figure1)

Kaplan-Meier survival curve comparing event rates over 24 months between Placebo and Amlodipine groups, showing time in months on the x-axis and event rate on the y-axis with a statistical summary inset including p-value and hazard ratio.*

FDA Label Image

Figure2 (Figure2)

A forest plot chart displaying hazard ratios with 95% confidence intervals across various patient subgroups, comparing outcomes favoring Amlodipine versus Placebo. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease status, baseline vessels with stenosis, and PCI stent strata. The horizontal axis represents the hazard ratio scale.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the cumulative incidence percentage over a period of 3.5 years, comparing Atorvastatin and placebo groups. The graph shows the Atorvastatin group with a consistently lower cumulative incidence than the placebo group, with a hazard ratio of 0.64 (95% CI 0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure4 (Figure4)

A line chart comparing cumulative hazard percentages over time for Placebo and Atorvastatin groups. The x-axis represents years (up to 5 years) until the first primary endpoint, and the y-axis shows cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Figure5 (Figure5)

A Kaplan-Meier survival curve chart comparing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) for Atorvastatin 10 mg (dashed line) versus Atorvastatin 80 mg (solid line). The chart includes hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical significance.*

FDA Label Image

Structure (Structure)

Chemical structure diagram showing the molecular structures of Amlodipine besylate and Atorvastatin calcium, the active ingredients in the medication. Each structure is labeled accordingly, depicting their distinct chemical formulas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.